Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3150 of 3173 entries
View as:

CP-690,550 and Midazolam Drug-Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT00902460 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT02100514 Org: User:
Start: 10/28/14 End: 07/10/17 Due: 07/10/18

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

Phase: N/A Priority: Normal
NCT ID: NCT06215118 Org: User:
Start: 02/20/24 End: 03/09/28 Due: 03/09/29

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Phase: N/A Priority: Normal
NCT ID: NCT04821622 Org: User:
Start: 05/12/21 End: 08/07/27 Due: 08/07/28

Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT03395197 Org: User:
Start: 12/18/17 End: 12/31/25 Due: 12/31/26

A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B

Phase: N/A Priority: Normal
NCT ID: NCT00002306 Org: User:
Start: - End: - Due: -

Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States

Phase: N/A Priority: Normal
NCT ID: NCT03353480 Org: User:
Start: 12/20/17 End: 02/26/18 Due: 02/26/19

Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04091087 Org: User:
Start: 06/26/20 End: 10/19/21 Due: 10/19/22

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Phase: N/A Priority: Normal
NCT ID: NCT03275740 Org: User:
Start: 07/17/17 End: 01/06/23 Due: 01/06/24

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03422822 Org: User:
Start: 03/08/18 End: 12/31/25 Due: 12/31/26

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT05579977 Org: User:
Start: 10/27/22 End: 09/22/23 Due: 09/22/24

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04649242 Org: User:
Start: 01/15/21 End: 01/09/29 Due: 01/09/30

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04618913 Org: User:
Start: 12/14/20 End: 08/31/25 Due: 08/31/26

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01276639 Org: User:
Start: 03/31/11 End: 04/30/13 Due: 04/30/14

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00263874 Org: User:
Start: 11/30/05 End: 09/30/06 Due: 09/30/07

Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Phase: N/A Priority: Normal
NCT ID: NCT05630976 Org: User:
Start: 02/07/23 End: 04/26/25 Due: 04/26/26

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Phase: N/A Priority: Normal
NCT ID: NCT05701007 Org: User:
Start: 02/13/23 End: 04/10/24 Due: 04/10/25

A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00902681 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01474941 Org: User:
Start: 06/30/11 End: 08/31/11 Due: 08/31/12

Consistency of Response With Rimegepant in Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06898047 Org: User:
Start: 04/30/25 End: 09/15/26 Due: 09/15/27

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.

Phase: N/A Priority: Normal
NCT ID: NCT06163677 Org: User:
Start: 01/17/24 End: 01/17/24 Due: 01/17/25

Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04987944 Org: User:
Start: 10/18/21 End: 04/04/23 Due: 04/04/24

Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004071 Org: User:
Start: 08/31/99 End: 09/30/07 Due: 09/30/08

A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05339334 Org: User:
Start: 03/10/22 End: 04/21/22 Due: 04/21/23

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00089648 Org: User:
Start: 12/31/04 End: 03/31/08 Due: 03/31/09